Published Date: 29 Mar 2025
Surgery may not be the best next course of treatment for patients with early-stage breast cancer who had a complete response to neoadjuvant (pre-surgical) chemotherapy and standard radiation treatment, according to new data ...
Read Full NewsTest your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on FcRn-blocking therapies in neurology!
Andrea Rossetti, MD, director of the EEG/Epilepsy Unit at the Department of Clinical Neurosciences the Lausanne University Hospital in Switzerland, offers insight into post-resuscitation epilepsy care.
Here's some of what is coming soon to NeurologyLive® this week.
Orelabrutinib Achieves Primary Endpoint in Phase 2b SLE Trial
Getting Through the Door: How COPD, Lung Cancer Screening Remains Minimal
Phase 3 VALIANT Results for Pegcetacoplan In C3G, IC-MPGN, With Andrew Bomback, MD
Intensive Weight Loss Before Colorectal Cancer Surgery Safe, Feasible
1.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
2.
Scientists discover the 'roadmap' that aggressive cancer uses to spread
3.
Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.
4.
Metastatic breast cancer can be effectively treated with cyclical estrogen and anti-estrogen therapy.
5.
In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.
1.
Unlocking the Potential of Elotuzumab: A Promising New Cancer Treatment
2.
Emerging and Innovative Therapies in Cancer Treatment and Post-Surgical Care
3.
Neutrophil Profiling and AI Rewrites Cancer Diagnosis
4.
Angina Haemorrhagica Bullosa: What You Need to Know
5.
Targeted Therapy: Latest Advances, Learning Tools, Trials & Treatment Options Explained
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
4.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
5.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation